FindTrial
Sign In

The dose-response of metaraminol for preventing post spinal anesthesia hypotension undergoing cesarean delivery

The dose-response of metaraminol for preventing post spinal anesthesia hypotension undergoing cesarean delivery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029490
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-17
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

control group:saline
group 0.25:0.25ug/kg/min of metaraminol
gorup 1.0:1 ug/kg/min of metaraminol
group 1.75: 1.75 ug/kg/min of metaraminol
group 2.5:2.5ug/kg/min of metaraminol

Sponsors

Jiaxing University Affiliated Women and Chilren Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patents with singleton pregnancy, ASA statue I or II and scheduled elective cesarean delivery, height 150-175cm.

Exclusion criteria

Exclusion criteria: Preeclampsia or hypertension, preexisting or gestational diabetes, BMI> 35 kg/m2, contradictions to local anesthesia.

Design outcomes

Primary

MeasureTime frame
ED50 AND ED95;—

Secondary

MeasureTime frame
BP;umbilical artery blood;—

Countries

China

Contacts

Public ContactFei Xiao

Jiaxing University Affiliated Women and Chilren Hospital

13706597501@163.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026